New Blood Test Predicts Dementia Up to 15 Years Early, Aiding Drug Therapy

Researchers have identified key proteins that can forecast dementia with high accuracy, potentially revolutionizing early treatment and care.

A groundbreaking blood test has been developed to predict dementia up to 15 years before diagnosis, offering hope for early intervention.
Scientists have discovered 11 proteins that accurately predict dementia in more than 90% of cases, marking a significant advancement in detection.
The test could enable the effective use of new Alzheimer's drugs, such as donanemab and lecanemab, which require early diagnosis for optimal results.
The UK's NHS is considered for integrating the test as a routine screening tool, highlighting its potential for widespread implementation.
Concerns remain about the current lack of early diagnosis and the need for healthcare system adjustments to accommodate new treatments.